Type and hit ENTER

Footer – After

Shout WordPress Theme by Pirenko.

Made in Portugal. With Love.

New data demonstrates high potential of NEATstik® as a rapid point-of-care monitoring tool for lung diseases

June 3, 2019
Positive early data from the BRIDGE1 study, a three-year 1000+ patient study in …
ProAxsis to present data on novel immunoassay at 2018 British Thoracic Society Winter Meeting

November 26, 2018
The potential benefits of ProAxsis’ novel ProteaseTag® Active Proteinase 3 Immunoassay will be discussed …
ProAxsis assays selected for inclusion in major new ERS-funded study

September 20, 2018
ProAxsis Limited (www.proaxsis.com), the Belfast-based company focused on developing new assays for the measurement …

ProAxsis

RT @Shoemelia: My PhD thesis title in 2010 was ‘non-invasive measures of inflammation in bronchiectasis’. Thesis Conclusion: I can’t find a…

45 days ago

NEATstik®, a simple point-of-care semi-quantitative neutrophil elastase assay, can identify bronchiectasis patients… https://t.co/jaKzh9gs4n

65 days ago

RT @BlfResearch: I just published A ‘pregnancy test’ for chest infections? https://t.co/YyN7ydZOfE

72 days ago

RT @BLFScotland: You could soon be taking a test at home to find out if you have a chest infection, thanks to new research by @lunguk Profe…

72 days ago

Footer - After | ProAxsis